@article{kapetanovic_risk_2018,
	title = {The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the {Malmö} {Preventive} {Project} cohort in southern {Sweden}},
	volume = {20},
	issn = {1478-6362},
	shorttitle = {The risk of clinically diagnosed gout by serum urate levels},
	url = {https://doi.org/10.1186/s13075-018-1697-6},
	doi = {10.1186/s13075-018-1697-6},
	abstract = {Hyperuricemia (HU) is in the causal pathway for developing clinical gout. There are few population-based assessments of the absolute and relative risk of clinically diagnosed incident gout in subjects with HU. We aimed to explore the long-term risk of developing incident gout among asymptomatic adults with different levels of serum urate (SU).},
	number = {1},
	urldate = {2018-10-04},
	journal = {Arthritis Research \& Therapy},
	author = {Kapetanovic, Meliha C. and Nilsson, Peter and Turesson, Carl and Englund, Martin and Dalbeth, Nicola and Jacobsson, Lennart},
	month = aug,
	year = {2018},
	pages = {190},
}

{"_id":"i8BEcNipQDd2rdwLC","bibbaseid":"kapetanovic-nilsson-turesson-englund-dalbeth-jacobsson-theriskofclinicallydiagnosedgoutbyserumuratelevelsresultsfrom30yearsfollowupofthemalmpreventiveprojectcohortinsouthernsweden-2018","author_short":["Kapetanovic, M. C.","Nilsson, P.","Turesson, C.","Englund, M.","Dalbeth, N.","Jacobsson, L."],"bibdata":{"bibtype":"article","type":"article","title":"The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden","volume":"20","issn":"1478-6362","shorttitle":"The risk of clinically diagnosed gout by serum urate levels","url":"https://doi.org/10.1186/s13075-018-1697-6","doi":"10.1186/s13075-018-1697-6","abstract":"Hyperuricemia (HU) is in the causal pathway for developing clinical gout. There are few population-based assessments of the absolute and relative risk of clinically diagnosed incident gout in subjects with HU. We aimed to explore the long-term risk of developing incident gout among asymptomatic adults with different levels of serum urate (SU).","number":"1","urldate":"2018-10-04","journal":"Arthritis Research & Therapy","author":[{"propositions":[],"lastnames":["Kapetanovic"],"firstnames":["Meliha","C."],"suffixes":[]},{"propositions":[],"lastnames":["Nilsson"],"firstnames":["Peter"],"suffixes":[]},{"propositions":[],"lastnames":["Turesson"],"firstnames":["Carl"],"suffixes":[]},{"propositions":[],"lastnames":["Englund"],"firstnames":["Martin"],"suffixes":[]},{"propositions":[],"lastnames":["Dalbeth"],"firstnames":["Nicola"],"suffixes":[]},{"propositions":[],"lastnames":["Jacobsson"],"firstnames":["Lennart"],"suffixes":[]}],"month":"August","year":"2018","pages":"190","bibtex":"@article{kapetanovic_risk_2018,\n\ttitle = {The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the {Malmö} {Preventive} {Project} cohort in southern {Sweden}},\n\tvolume = {20},\n\tissn = {1478-6362},\n\tshorttitle = {The risk of clinically diagnosed gout by serum urate levels},\n\turl = {https://doi.org/10.1186/s13075-018-1697-6},\n\tdoi = {10.1186/s13075-018-1697-6},\n\tabstract = {Hyperuricemia (HU) is in the causal pathway for developing clinical gout. There are few population-based assessments of the absolute and relative risk of clinically diagnosed incident gout in subjects with HU. We aimed to explore the long-term risk of developing incident gout among asymptomatic adults with different levels of serum urate (SU).},\n\tnumber = {1},\n\turldate = {2018-10-04},\n\tjournal = {Arthritis Research \\& Therapy},\n\tauthor = {Kapetanovic, Meliha C. and Nilsson, Peter and Turesson, Carl and Englund, Martin and Dalbeth, Nicola and Jacobsson, Lennart},\n\tmonth = aug,\n\tyear = {2018},\n\tpages = {190},\n}\n\n","author_short":["Kapetanovic, M. C.","Nilsson, P.","Turesson, C.","Englund, M.","Dalbeth, N.","Jacobsson, L."],"key":"kapetanovic_risk_2018","id":"kapetanovic_risk_2018","bibbaseid":"kapetanovic-nilsson-turesson-englund-dalbeth-jacobsson-theriskofclinicallydiagnosedgoutbyserumuratelevelsresultsfrom30yearsfollowupofthemalmpreventiveprojectcohortinsouthernsweden-2018","role":"author","urls":{"Paper":"https://doi.org/10.1186/s13075-018-1697-6"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/groups/2575433/items?key=DE7AwkgUPeLruRBgvUzdo0Xc&format=bibtex&limit=100","dataSources":["QDub7pfxdk2ms2NxS","5jEuhQhgRx3py8LmG"],"keywords":[],"search_terms":["risk","clinically","diagnosed","gout","serum","urate","levels","results","years","follow","malm","preventive","project","cohort","southern","sweden","kapetanovic","nilsson","turesson","englund","dalbeth","jacobsson"],"title":"The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden","year":2018}